In conclusion, Gal4 overexpression in PDA correlates with better prognosis and survival as well as with a reduction of tumor cell migration, invasion, and metastasis, therefore suggesting its role as a tumor suppressor in pancreatic cancer. Here, LGALS4 is linked to Patent ductus arteriosus.